Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 10:42AM ET
177.52
Dollar change
-2.13
Percentage change
-1.19
%
IndexS&P 500 P/E60.96 EPS (ttm)2.91 Insider Own0.78% Shs Outstand69.91M Perf Week7.59%
Market Cap12.41B Forward P/E46.17 EPS next Y3.85 Insider Trans-7.88% Shs Float69.38M Perf Month1.13%
Income206.30M PEG3.37 EPS next Q0.40 Inst Own102.42% Short Float4.49% Perf Quarter-14.47%
Sales1.70B P/S7.31 EPS this Y2.52% Inst Trans-0.61% Short Ratio3.58 Perf Half Y33.02%
Book/sh10.48 P/B16.94 EPS next Y27.58% ROA8.53% Short Interest3.12M Perf Year-43.87%
Cash/sh10.07 P/C17.63 EPS next 5Y18.10% ROE34.12% 52W Range125.82 - 335.91 Perf YTD-18.19%
Dividend Est.- P/FCF177.85 EPS past 5Y122.47% ROI9.69% 52W High-47.15% Beta1.00
Dividend TTM- Quick Ratio2.58 Sales past 5Y24.75% Gross Margin68.32% 52W Low41.09% ATR (14)5.72
Dividend Ex-Date- Current Ratio3.47 EPS Y/Y TTM4337.69% Oper. Margin12.96% RSI (14)56.18 Volatility3.51% 3.53%
Employees3000 Debt/Eq1.98 Sales Y/Y TTM30.02% Profit Margin12.16% Recom1.50 Target Price236.02
Option/ShortYes / Yes LT Debt/Eq1.91 EPS Q/Q509.02% Payout0.00% Rel Volume0.43 Prev Close179.65
Sales Surprise10.52% EPS Surprise120.52% Sales Q/Q37.90% EarningsFeb 22 AMC Avg Volume869.83K Price177.52
SMA205.19% SMA50-0.03% SMA200-8.93% Trades Volume84,722 Change-1.19%
Date Action Analyst Rating Change Price Target Change
Dec-21-23Upgrade Robert W. Baird Neutral → Outperform $180 → $238
Dec-04-23Upgrade Morgan Stanley Equal-Weight → Overweight $185 → $234
Oct-02-23Upgrade Jefferies Hold → Buy $260 → $240
Aug-21-23Upgrade Citigroup Neutral → Buy $273 → $265
Aug-21-23Downgrade Robert W. Baird Outperform → Neutral $320 → $219
May-30-23Resumed Morgan Stanley Equal-Weight $343
Jan-26-23Initiated Wolfe Research Peer Perform
Nov-04-22Upgrade Piper Sandler Neutral → Overweight $235 → $340
Oct-18-22Initiated Barclays Equal Weight $238
Oct-12-22Initiated Jefferies Hold $260
Apr-10-24 06:15PM
Apr-03-24 06:00AM
Apr-02-24 09:45AM
Mar-28-24 09:55AM
Mar-26-24 05:10AM
09:17AM Loading…
Mar-21-24 09:17AM
06:40AM
Mar-20-24 08:11AM
06:00AM
Mar-19-24 06:39AM
06:14AM
Mar-18-24 08:23AM
Mar-14-24 09:45AM
Mar-08-24 06:00AM
Mar-05-24 06:00AM
05:30AM Loading…
Mar-04-24 05:30AM
Feb-29-24 07:12AM
Feb-28-24 08:59AM
Feb-27-24 09:35AM
Feb-26-24 06:04PM
Feb-23-24 12:40PM
12:30PM
12:10PM
08:40AM
Feb-22-24 06:00PM
05:20PM
04:32PM
04:18PM
04:07PM
04:07PM
09:15AM Loading…
Feb-19-24 09:15AM
Feb-18-24 01:26PM
Feb-16-24 08:27AM
Feb-13-24 04:01PM
Feb-12-24 10:01AM
Feb-08-24 09:52AM
04:45AM
Feb-07-24 06:00AM
Feb-05-24 12:45PM
Feb-01-24 10:26AM
Jan-31-24 08:13PM
Jan-22-24 09:45AM
Jan-18-24 04:01PM
Jan-12-24 09:37AM
Jan-11-24 06:00AM
Jan-08-24 09:51AM
Jan-05-24 09:45AM
Dec-29-23 12:45PM
Dec-28-23 01:13PM
09:01AM
Dec-26-23 02:30PM
Dec-21-23 01:31AM
Dec-20-23 05:14AM
Dec-14-23 07:56PM
Dec-13-23 12:45PM
Dec-11-23 04:32PM
Dec-08-23 05:33AM
05:26AM
Dec-07-23 04:42AM
Dec-04-23 09:53AM
Nov-30-23 04:45PM
12:43PM
Nov-28-23 06:00AM
Nov-27-23 12:45PM
Nov-26-23 03:11PM
Nov-23-23 11:46AM
11:30AM
Nov-19-23 06:10AM
Nov-17-23 10:54AM
08:45AM
Nov-13-23 09:31AM
Nov-10-23 12:45PM
Nov-08-23 12:20PM
Nov-07-23 08:00AM
05:05AM
Nov-06-23 09:56AM
09:55AM
09:30AM
Nov-04-23 01:13AM
Nov-03-23 08:02PM
04:08PM
11:15AM
11:04AM
10:59AM
10:31AM
10:13AM
08:07AM
Nov-02-23 07:01PM
05:30PM
04:07PM
04:01PM
10:24AM
Nov-01-23 06:27PM
09:53AM
09:00AM
06:00AM
Oct-31-23 10:01AM
07:37AM
Oct-30-23 11:27AM
09:45AM
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petrovic ShaceyDirectorFeb 28 '24Option Exercise92.1111,6091,069,30514,176Feb 29 04:37 PM
Petrovic ShaceyDirectorFeb 28 '24Sale162.9211,6091,891,3382,567Feb 29 04:37 PM
BORIO LUCIANADirectorDec 15 '23Sale207.087214,9102,278Dec 18 04:01 PM
Petrovic ShaceyDirectorNov 13 '23Option Exercise81.6920,0001,633,73322,567Nov 14 04:04 PM
Petrovic ShaceyDirectorNov 13 '23Sale164.3320,0003,286,6002,567Nov 14 04:04 PM
Petrovic ShaceyDirectorNov 13 '23Sale165.0215,0002,475,3000Nov 14 04:04 PM
Singh PremSVP, Global OperationsSep 19 '23Buy168.9211694,032Sep 21 04:48 PM
Hollingshead JamesPresident and CEOAug 28 '23Buy181.415,5501,006,82634,177Aug 29 04:07 PM
McMillan Wayde D.EVP, CFOJul 03 '23Sale282.941,388392,72121,477Jul 06 04:11 PM
Manea DanSVP, Chief HR OfficerJun 20 '23Sale290.0017550,7504,522Jun 21 04:09 PM
BORIO LUCIANADirectorJun 05 '23Sale283.38500141,6902,350Jun 06 04:11 PM
Petrovic ShaceyDirectorJun 01 '23Sale271.5615,0004,073,40043,205Jun 02 04:05 PM
MINOGUE MICHAEL RDirectorMay 23 '23Buy304.753,3001,005,67512,221May 24 04:11 PM